-
Add to Cart The item has been added17987-1CAS Number: 851881-60-2 Molecular Formula: C<sub>20</sub>H<sub>17</sub>F<sub>2</sub>N<sub>3</sub>O2 Formula Weight: 369.4 -
Add to Cart The item has been added17987-10CAS Number: 851881-60-2 Molecular Formula: C<sub>20</sub>H<sub>17</sub>F<sub>2</sub>N<sub>3</sub>O2 Formula Weight: 369.4
-
Add to Cart The item has been added17987-25CAS Number: 851881-60-2 Molecular Formula: C<sub>20</sub>H<sub>17</sub>F<sub>2</sub>N<sub>3</sub>O2 Formula Weight: 369.4
-
Add to Cart The item has been added17987-5CAS Number: 851881-60-2 Molecular Formula: C<sub>20</sub>H<sub>17</sub>F<sub>2</sub>N<sub>3</sub>O2 Formula Weight: 369.4
-
Add to Cart The item has been added14321-100A water soluble, irreversible, broad spectrum inhibitor of serine proteases, including trypsin, chymotrypsin, plasmin, thrombin, and kallikreins also inhibits NADPH oxidase.
-
Add to Cart The item has been added14321-250A water soluble, irreversible, broad spectrum inhibitor of serine proteases, including trypsin, chymotrypsin, plasmin, thrombin, and kallikreins also inhibits NADPH oxidase.
-
Add to Cart The item has been added14321-50A water soluble, irreversible, broad spectrum inhibitor of serine proteases, including trypsin, chymotrypsin, plasmin, thrombin, and kallikreins also inhibits NADPH oxidase.
-
Add to Cart The item has been added18416-1An inhibitor of EGFR and VEGFR tyrosine kinases (IC<sub>50</sub>s = 2, 6, 77, and 59 nM for EGFR, ErbB2, KDR, and FLT1, respectively) demonstrates antitumor activity and anti-angiogenic activity in numerous in vitro and in vivo models.
-
Add to Cart The item has been added18416-10An inhibitor of EGFR and VEGFR tyrosine kinases (IC<sub>50</sub>s = 2, 6, 77, and 59 nM for EGFR, ErbB2, KDR, and FLT1, respectively) demonstrates antitumor activity and anti-angiogenic activity in numerous in vitro and in vivo models.
-
Add to Cart The item has been added18416-25An inhibitor of EGFR and VEGFR tyrosine kinases (IC<sub>50</sub>s = 2, 6, 77, and 59 nM for EGFR, ErbB2, KDR, and FLT1, respectively) demonstrates antitumor activity and anti-angiogenic activity in numerous in vitro and in vivo models.
-
Add to Cart The item has been added18416-5An inhibitor of EGFR and VEGFR tyrosine kinases (IC<sub>50</sub>s = 2, 6, 77, and 59 nM for EGFR, ErbB2, KDR, and FLT1, respectively) demonstrates antitumor activity and anti-angiogenic activity in numerous in vitro and in vivo models.
-
Add to Cart The item has been added18321-1An inhibitor of Nrf2-induced gene transcription at the antioxidant response element in cells at 1 to 10 µM sensitizes lung carcinoma A549 cells to chemotherapeutic agents and inhibits the growth of A549 cells in vitro and in vivo in animals.
